Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Study of Recombinant Human Albumin Injection for the Treatment of Hypoalbuminemia in Cirrhotic Patients With Ascites

NCT06911554 is registered in ClinicalTrials.gov with Tonghua Anrate Biopharmaceutical Co., Ltd. as lead sponsor.

NCT NCT06911554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06911554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Study of Recombinant Human Albumin Injection for the Treatment of Hypoalbuminemia in Cirrhotic Patients With Ascites
Lead sponsor
Tonghua Anrate Biopharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
June 16, 2023
Completion date
September 27, 2024
Enrollment
416 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic ascites